Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bovine Serum Albumin-Coated Niclosamide-Zein Nanoparticles as Potential Injectable Medicine against COVID-19
Sanoj Rejinold N, Goeun Choi, Huiyan Piao, et al.
Materials (2021) Vol. 14, Iss. 14, pp. 3792-3792
Open Access | Times Cited: 19

Showing 19 citing articles:

Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments
Niaz Mahmud, Muzahidul I. Anik, M. Khalid Hossain, et al.
ACS Applied Bio Materials (2022) Vol. 5, Iss. 6, pp. 2431-2460
Closed Access | Times Cited: 45
Zein Microparticles and Nanoparticles as Drug Delivery Systems
Iolanda De Marco
Polymers (2022) Vol. 14, Iss. 11, pp. 2172-2172
Open Access | Times Cited: 41
Association of bovine serum albumin and cetyltrimethylammonium chloride: An investigation of the effects of temperature and hydrotropes
Sumaya Islam Progga, Javed Masood Khan, Tajmul Hasan, et al.
International Journal of Biological Macromolecules (2023) Vol. 246, pp. 125592-125592
Closed Access | Times Cited: 27
Co-encapsulation of curcumin and resveratrol in zein-bovine serum albumin nanoparticles using a pH-driven method
Xiao Chen, Yu Chong, Yi Zhang, et al.
Food & Function (2023) Vol. 14, Iss. 7, pp. 3169-3178
Closed Access | Times Cited: 25
Nanoencapsulation and delivery of bioactive ingredients using zein nanocarriers: approaches, characterization, applications, and perspectives
Yanlin Lei, Youngsoo Lee
Food Science and Biotechnology (2024) Vol. 33, Iss. 5, pp. 1037-1057
Closed Access | Times Cited: 7
Phase separation, aggregation, and complexation of triton-X100 and bovine serum albumin mixture: A combined cloud point and UV–visible spectroscopic approaches
Habiba Akhter Bhuiyan, Javed Masood Khan, Dileep Kumar, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 132184-132184
Closed Access | Times Cited: 7
Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview
Omid Gholizadeh, Saman Yasamineh, Parya Amini, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 28
Aggregation and thermodynamic study of bovine serum albumin + cationic surfactant mixture in short chain alcoholic media: Effect of composition and temperature
Habiba Akhter Bhuiyan, Malik Abdul Rub, Shamim Mahbub, et al.
Journal of Saudi Chemical Society (2022) Vol. 26, Iss. 3, pp. 101451-101451
Open Access | Times Cited: 20
Development of Carvedilol-Loaded Albumin-Based Nanoparticles with Factorial Design to Optimize In Vitro and In Vivo Performance
Mohamed S. Attia, Mohamed F. Radwan, Tarek S. Ibrahim, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1425-1425
Open Access | Times Cited: 8
Development of Chitosan/Gelatin-Based Hydrogels Incorporated with Albumin Particles
Magdalena Bańkosz
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14136-14136
Open Access | Times Cited: 10
The assessment of pharmacokinetics and neuroprotective effect of berberine hydrochloride-embedded albumin nanoparticles via various administration routes: comparative in-vivo studies in rats
Hany G. Attia, Maha E. Elmataeeshy, Mohamed Aleraky, et al.
Journal of Microencapsulation (2024), pp. 1-25
Closed Access | Times Cited: 1
Revisiting Niclosamide Formulation Approaches – a Pathway Toward Drug Repositioning
Mario Jug, Flavia Laffleur, Gioconda Millotti
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 4153-4182
Open Access | Times Cited: 1
NICLOSAMIDE: A POTENTIAL TREATMENT OPTION FOR COVID-19
S. K. Vibhute, Aditi Kasar, HRISHIKESH MAHALE, et al.
International Journal of Applied Pharmaceutics (2023), pp. 50-56
Open Access | Times Cited: 4
The Next Generation COVID‐19 Antiviral; Niclosamide‐Based Inorganic Nanohybrid System Kills SARS‐CoV‐2
Goeun Choi, N. Sanoj Rejinold, Huiyan Piao, et al.
Small (2023)
Closed Access | Times Cited: 4
Niclosamide-Exfoliated Anionic Clay Nanohybrid Repurposed as an Antiviral Drug for Tackling Covid-19; Oral Formulation with Tween 60/Eudragit S100
N. Sanoj Rejinold, Huiyan Piao, Goeun Choi, et al.
Clays and Clay Minerals (2021) Vol. 69, Iss. 5, pp. 533-546
Open Access | Times Cited: 9
Potential Application of Bionanoparticles to Treat Severe Acute Respiratory Syndrome Coronavirus-2 Infection
Sujit Kumar Debnath, Rohit Srivastava
Frontiers in Nanotechnology (2022) Vol. 3
Open Access | Times Cited: 6
Experimental and Computational Characterization of the Molecular Interaction between Bovine Serum Albumin and an Ester‐functionalized Cationic Gemini Surfactant
Hira Lal, Mohd. Akram, KABIR‐UD‐DIN KABIR‐UD‐DIN
ChemistrySelect (2023) Vol. 8, Iss. 29
Closed Access | Times Cited: 2
Orally administered niclosamide-based organic/inorganic hybrid suppresses SARS-CoV-2 infection
Geun‐woo Jin, Goeun Choi, N. Sanoj Rejinold, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Research Progress in Nanopharmaceuticals with Different Delivery Routes in the Antivirus Field
Yenong Shi, Dongqiong He, Xianwei Zhang, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 25, pp. 1975-1991
Closed Access
Page 1

Scroll to top